Candel Therapeutics, Inc. (CADL) Form 10-Q Quarterly Reports
Candel Therapeutics, Inc. (CADL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CADL
CIK: 1841387
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerDavid Wilson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | 4 | 0001193125-26-412658 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 | 0001193125-26-412655 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 | 0001193125-26-412654 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 | 0001873905-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001950047-26-009295 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | 4 | 0001193125-26-387924 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-387919 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-06 | 8-K | 0001193125-26-387310 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001193125-26-386561 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001923794-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008263 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-347980 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-347957 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002278 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 | 0002139479-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-07-08 | 2026-07-06 | 3 | 0002139479-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 | 0001909680-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 | 0001923794-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 | 0001494695-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 | 0001242215-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 | 0001979825-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001950047-26-006607 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001950047-26-006597 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 | 0002013423-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 | 0001979825-26-000004 | View SEC Doc Filr Page |